-
Medtronic's defibrillator sees 98.7% success rate in global trial
Minneapolis-based devicemaker Medtronic found a 98.7 percent success rate for a defibrillator that isn't on the market in a global, company-sponsored study. The trial's goal was 88 percent. -
HHS invests $11M into monkeypox vaccine production
HHS is plugging $11 million into a Michigan facility tasked with filling vials with monkeypox vaccine Jynneos, the department said Aug. 29. -
Abbott resumes producing most popular baby formula
Abbott Nutrition is back to manufacturing Similac, its leading baby formula product, and the company said Aug. 26 it expects to provide it to buyers by mid-October. -
Memorial Health System joins Health Trust for supply chain resiliency
Gulfport, Miss.-based Memorial Health System joined Nashville, Tenn.-based HealthTrust for supply chain resiliency under a multiyear group purchasing agreement. HealthTrust will serve as the health network's exclusive group purchasing organization. -
Lacking funds, White House to stop delivery of free COVID-19 tests
The federal government plans to halt its program that delivers free, at-home COVID-19 tests on Sept. 2 because of dwindling funds, according to reports from CNN and NBC News. -
N95 masks aren't in shortage anymore, FDA says
The COVID-19 pandemic shoved the nation's weak supply of personal protective equipment into the limelight when hospitals scrambled to grab enough gowns, medical masks and gloves in 2020. More than two years later, N95 respirator masks exited the FDA's medical device shortage list. -
10 systems seeking supply chain talent
Here are 10 health systems and hospitals that have posted job listings seeking supply chain expertise in the last week: -
3 strategies for a stronger supply chain: McKinsey survey
With some hospitals and health systems spending up to 40 percent of their budgets on supply, consulting company McKinsey compiled supply chain executives' main strategies at bolstering their work and published the results Aug. 23. -
Monkeypox vaccine dose-sparing causes headaches for public health officials
The latest strategy to stretch the supply of the world's only monkeypox vaccine, Bavarian Nordic's Jynneos, is frustrating local health officials tasked with distributing the doses, Politico reported Aug. 24. -
Hobbs Medical selects new president
Medical equipment manufacturer Hobbs Medical appointed John Kirwan as its next president, effective immediately. -
5 recent medical supplier acquisitions, partnerships
Here are five recent acquisitions, deals and partnerships that have sprung up since Aug. 16: -
Medtronic recalls 87K short circuiting defibrillators
Medtronic recalled 87,709 defibrillators Aug. 19 in a class 1 recall, the most serious type, after 27 complaints have reported the device delivering an electric shock at a too-low voltage. -
Blood supply levels drop 50% since early summer, supplier says
Vitalant's blood supply has dropped by nearly 50 percent since early summer, the supplier said Aug. 22, urging people to donate ahead of Labor Day weekend. -
Supply Chain Tip of the Week: Achieve supply chain resiliency with the right inventory management strategy
In a Q&A with Cardinal Health and Becker’s Hospital Review, Joe Walsh, founder of Supply Chain Sherpas, discussed how supply chain leaders can best prepare for the 2022. -
US to boost monkeypox vaccine supplies: 2 updates
An additional 1.8 million doses of the Jynneos monkeypox vaccine will be available for health departments to order starting Aug. 22, according to White House officials. -
10 systems seeking supply chain talent
Here are 10 health systems that have posted job listings seeking supply chain expertise in the last week: -
New York urges White House to boost monkeypox vaccine production
As monkeypox vaccine supply wanes, members of Congress from New York called on the Biden Administration Aug. 16 to invoke the Defense Protection Act, which they say would ramp up domestic production. -
GSK inks deal with UNICEF to provide 18M malaria vaccines
With a $170 million deal, UNICEF will acquire 18 million malaria vaccines from GSK, a global pharmaceutical company based in London. -
Monkeypox vaccine-maker warns it can't keep up with demand
The world's only pharmaceutical company with an approved monkeypox vaccine said it can't match the current demand and may move to outsourcing production, Bloomberg reported Aug. 17. -
In a few months, anyone can buy a hearing aid
Five years after the Over-the-Counter Hearing Aid Act was signed into law, hearing aids will soon be available to people online and on store shelves regardless of a medical appointment, according to the FDA.
Page 36 of 50